Evidence map›Paper›PMID 37767403›Full record

ArticleFrontiers in pharmacology2023

A hypothermia mimetic molecule (zr17-2) reduces ganglion cell death, gliosis, and electroretinogram distortion in male rats subjected to perinatal asphyxia.

Manuel Rey-Funes, Juan Carlos Fernández, Rafael Peláez, Manuel Soliño, Daniela S Contartese, Nicolás S Ciranna, Ronan Nakamura, Aníbal Sarotto, Verónica B Dorfman, José M Zapico and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Manuel Rey-FunesLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Juan Carlos FernándezLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Rafael PeláezBiomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain.
Manuel SoliñoLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Daniela S ContarteseLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Nicolás S CirannaLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Ronan NakamuraLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Aníbal SarottoLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Verónica B DorfmanCentro de Estudios Biomédicos Básicos, Aplicados y Desarrollo (CEBBAD), Universidad Maimónides, Buenos Aires, Argentina.
José M ZapicoDepartment of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
Ana RamosDepartment of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
Beatriz de Pascual-TeresaDepartment of Chemistry and Biochemistry, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
Juan José López-CostaLaboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Ignacio M Larrayoz *Department of Nursing, Biomarkers, Artificial Intelligence, and Signaling (BIAS), University of La Rioja, Logroño, Spain.
Alfredo Martínez *Angiogenesis Group, Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain.
César Fabián Loidl *Laboratorio de Neuropatología Experimental, Instituto de Biología Celular y Neurociencia "Prof. E. De Robertis" (IBCN), Facultad de Medicina, CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
Universidad de Buenos Aires · ARUniversidad San Pablo CEU · ESCenter for Biomedical Research of La Rioja · ESUniversidad de La Rioja · ESUniversidad Maimónides · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosiscold-shock proteinselectroretinogramgliosishypothermiahypothermia mimeticsperinatal asphyxia

Identifiers

PMID37767403
PMCPMC10520548
OpenAlexW4386614742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.